Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors

An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors....

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 23; no. 3; p. 679
Main Authors Salomatina, Oksana, Popadyuk, Irina, Zakharenko, Alexandra, Zakharova, Olga, Fadeev, Dmitriy, Komarova, Nina, Reynisson, Jóhannes, Arabshahi, H., Chand, Raina, Volcho, Konstantin, Salakhutdinov, Nariman, Lavrik, Olga
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 17.03.2018
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.
AbstractList An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.
An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC 50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.
An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.
An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.
Author Chand, Raina
Popadyuk, Irina
Lavrik, Olga
Reynisson, Jóhannes
Salakhutdinov, Nariman
Salomatina, Oksana
Zakharova, Olga
Komarova, Nina
Arabshahi, H.
Zakharenko, Alexandra
Volcho, Konstantin
Fadeev, Dmitriy
AuthorAffiliation 1 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SB RAS, acad. Lavrentjev ave. 9, Novosibirsk 630090, Russia; ana@nioch.nsc.ru (O.V.S.); popadyuk@nioch.nsc.ru (I.I.P.); dsf@nioch.nsc.ru (D.S.F.); komar@nioch.nsc.ru (N.I.K); anvar@nioch.nsc.ru (N.F.S.)
3 School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand; j.reynisson@auckland.ac.nz (J.R.); j.arabshahi@auckland.ac.nz (H.J.A.); rcha387@aucklanduni.ac.nz (R.C.)
4 Novosibirsk State University, Pirogova str. 2, Novosibirsk 630090, Russia
2 Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SB RAS, acad. Lavrentjev ave. 8, Novosibirsk 630090, Russia; sashaz@niboch.nsc.ru (A.L.Z); isar@niboch.nsc.ru (O.D.Z.); lavrik@niboch.nsc.ru (O.I.L.)
AuthorAffiliation_xml – name: 1 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SB RAS, acad. Lavrentjev ave. 9, Novosibirsk 630090, Russia; ana@nioch.nsc.ru (O.V.S.); popadyuk@nioch.nsc.ru (I.I.P.); dsf@nioch.nsc.ru (D.S.F.); komar@nioch.nsc.ru (N.I.K); anvar@nioch.nsc.ru (N.F.S.)
– name: 2 Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SB RAS, acad. Lavrentjev ave. 8, Novosibirsk 630090, Russia; sashaz@niboch.nsc.ru (A.L.Z); isar@niboch.nsc.ru (O.D.Z.); lavrik@niboch.nsc.ru (O.I.L.)
– name: 3 School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand; j.reynisson@auckland.ac.nz (J.R.); j.arabshahi@auckland.ac.nz (H.J.A.); rcha387@aucklanduni.ac.nz (R.C.)
– name: 4 Novosibirsk State University, Pirogova str. 2, Novosibirsk 630090, Russia
Author_xml – sequence: 1
  givenname: Oksana
  surname: Salomatina
  fullname: Salomatina, Oksana
– sequence: 2
  givenname: Irina
  surname: Popadyuk
  fullname: Popadyuk, Irina
– sequence: 3
  givenname: Alexandra
  surname: Zakharenko
  fullname: Zakharenko, Alexandra
– sequence: 4
  givenname: Olga
  surname: Zakharova
  fullname: Zakharova, Olga
– sequence: 5
  givenname: Dmitriy
  surname: Fadeev
  fullname: Fadeev, Dmitriy
– sequence: 6
  givenname: Nina
  surname: Komarova
  fullname: Komarova, Nina
– sequence: 7
  givenname: Jóhannes
  orcidid: 0000-0003-4174-9512
  surname: Reynisson
  fullname: Reynisson, Jóhannes
– sequence: 8
  givenname: H.
  surname: Arabshahi
  fullname: Arabshahi, H.
– sequence: 9
  givenname: Raina
  surname: Chand
  fullname: Chand, Raina
– sequence: 10
  givenname: Konstantin
  orcidid: 0000-0002-4083-9324
  surname: Volcho
  fullname: Volcho, Konstantin
– sequence: 11
  givenname: Nariman
  surname: Salakhutdinov
  fullname: Salakhutdinov, Nariman
– sequence: 12
  givenname: Olga
  surname: Lavrik
  fullname: Lavrik, Olga
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29562592$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1v1DAQhiNURD_gB3BBlrhwCYy_4s0FaWkLrFQVJMrZcpxJ45U3Xuxkpf33OGyL2iJOtmbeeTQz75wWR0MYsCheU3jPeQ0fNsGjnTwmxoFDpepnxQkVDEoOoj568D8uTlNaAzAqqHxRHLNaVkzW7KTA67BDT37gxqX9MPY4OksuMLqdGd0OEwkd-eQ8kqV1bSImkcuuQzvnyM0-hrT35cX1knzvQ9r2oXWYRowmIaFkNfSucWOI6WXxvDM-4au796z4-fny5vxrefXty-p8eVVaUfOxtFDVChYNA-SoKuBdI1pacwBVVw2VnUDbSQHMGiGllQxb2kKNvBLQKaH4WbE6cNtg1nob3cbEvQ7G6T-BEG-1iXlCj7oTVcV5w3i1YMI2tJFolGkRsbWcC5lZHw-s7dRschCHMRr_CPo4M7he34adroAqxWfAuztADL-mvBedd2zRezNgmJJmWQfZBzVL3z6RrsMUh7wqzSgspKQLKrLqzcOO_rZy72YWqIPAZmNSxE5bN2Yfw9yg85qCnu9G_3M3uZI-qbyH_7_mN-WVyKU
CitedBy_id crossref_primary_10_1002_med_21587
crossref_primary_10_1007_s40487_021_00158_0
crossref_primary_10_1016_j_ejmech_2018_10_055
crossref_primary_10_1134_S1068162019060104
crossref_primary_10_3390_molecules26071945
crossref_primary_10_1016_j_jpcs_2023_111681
crossref_primary_10_3390_molecules25153496
crossref_primary_10_3390_ijms21010126
crossref_primary_10_3390_app9132767
crossref_primary_10_1134_S0026893321020060
crossref_primary_10_1016_j_pharmthera_2019_107396
crossref_primary_10_3390_molecules29030581
crossref_primary_10_1016_j_steroids_2020_108771
crossref_primary_10_3390_molecules24203711
crossref_primary_10_3390_ijms24065781
crossref_primary_10_3390_molecules24030381
crossref_primary_10_3390_molecules23102468
crossref_primary_10_3390_ijms22041780
crossref_primary_10_3390_s21144832
crossref_primary_10_3390_ijms21197162
crossref_primary_10_2174_1570180816666181220121042
crossref_primary_10_3390_molecules27010072
crossref_primary_10_1016_j_bmc_2019_115234
Cites_doi 10.3109/03602532.2014.971957
10.1016/j.bioorg.2017.12.005
10.2174/092986711796957266
10.1038/nrc1977
10.1038/sj.emboj.7601885
10.1073/pnas.211429198
10.1016/j.mrfmmm.2015.09.003
10.1016/j.bmc.2015.03.020
10.1016/j.chembiol.2010.04.012
10.1002/minf.201200103
10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO;2-W
10.1093/nar/gkt1260
10.2174/092986710790979971
10.1517/13543776.2011.604314
10.1021/jm300335n
10.1158/1078-0432.CCR-16-1193
10.1074/jbc.M111.333963
10.1016/j.dnarep.2009.02.002
10.1070/RCR4683
10.1038/nsb1203-980
10.1021/acs.jmedchem.5b00136
10.3390/molecules22101710
10.1021/acs.jmedchem.6b01565
10.1016/j.bmc.2016.09.016
10.1016/S0022-2836(02)01154-3
10.1021/ci800298z
10.1006/jmbi.1996.0897
10.1146/annurev.biochem.72.121801.161712
10.1002/prot.20588
10.1023/A:1007996124545
10.1016/0022-1759(83)90303-4
10.1016/j.febslet.2011.01.032
10.3390/molecules19033761
10.7717/peerj.3933
10.1016/j.bmc.2016.09.045
10.1007/s00280-003-0717-6
10.1093/nar/gkm463
10.1038/emboj.2009.302
10.3390/12082106
10.1016/S1074-5521(03)00021-8
10.1194/jlr.R049437
10.1038/nature08444
10.1074/jbc.M405042200
10.1007/s40262-017-0587-4
10.1093/nar/gkx1219
10.1021/jm901061s
10.2174/187152008784220357
10.1021/ja00467a001
10.1038/sj.emboj.7601869
10.1016/j.ejmech.2014.07.080
10.1021/acs.jnatprod.6b00979
10.1093/nar/28.1.235
ContentType Journal Article
Copyright 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2018 by the authors. 2018
Copyright_xml – notice: 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2018 by the authors. 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/molecules23030679
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_f46633b236824cb1b5ea7adeeedc3345
PMC6017735
29562592
10_3390_molecules23030679
Genre Journal Article
GroupedDBID ---
0R~
123
2WC
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIWK
ACPRK
ACUHS
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
E3Z
EBD
EMOBN
ESX
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
HZ~
I09
IHR
IPNFZ
KQ8
LK8
M1P
MODMG
O-U
O9-
OK1
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
SV3
TR2
TUS
UKHRP
~8M
3V.
ABJCF
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c493t-c069708b20e3e7603fb4d19300796b15f4ecf5402ca455c52ed1d09e3640f7473
IEDL.DBID 7X7
ISSN 1420-3049
IngestDate Wed Aug 27 01:29:33 EDT 2025
Thu Aug 21 14:08:18 EDT 2025
Fri Jul 11 08:30:53 EDT 2025
Fri Jul 25 19:59:00 EDT 2025
Wed Feb 19 02:43:46 EST 2025
Thu Apr 24 23:08:45 EDT 2025
Tue Jul 01 03:11:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Tdp1 inhibitor
amide
ursodeoxycholic acid
virtual screening
molecular modelling
tumor
cancer
deoxycholic acid
chenodeoxycholic acid
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c493t-c069708b20e3e7603fb4d19300796b15f4ecf5402ca455c52ed1d09e3640f7473
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4174-9512
0000-0002-4083-9324
OpenAccessLink https://www.proquest.com/docview/2108551814?pq-origsite=%requestingapplication%
PMID 29562592
PQID 2108551814
PQPubID 2032355
ParticipantIDs doaj_primary_oai_doaj_org_article_f46633b236824cb1b5ea7adeeedc3345
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6017735
proquest_miscellaneous_2017056275
proquest_journals_2108551814
pubmed_primary_29562592
crossref_citationtrail_10_3390_molecules23030679
crossref_primary_10_3390_molecules23030679
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20180317
PublicationDateYYYYMMDD 2018-03-17
PublicationDate_xml – month: 3
  year: 2018
  text: 20180317
  day: 17
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2018
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Nguyen (ref_26) 2015; 58
Wang (ref_27) 2017; 60
Popadyuk (ref_37) 2017; 86
Korb (ref_52) 2009; 49
Sharma (ref_38) 2011; 18
ref_54
Katyalm (ref_13) 2009; 8
Hofmann (ref_33) 2014; 55
Zakharenko (ref_29) 2016; 79
Mooij (ref_53) 2005; 61
Brossard (ref_41) 2014; 86
Alagoz (ref_19) 2014; 42
Borda (ref_12) 2015; 781
Jones (ref_49) 1997; 267
Katyal (ref_15) 2007; 26
Zakharenko (ref_25) 2015; 9
Zhu (ref_40) 2012; 31
Mosmann (ref_44) 1983; 65
Beretta (ref_6) 2010; 17
Zuma (ref_21) 2009; 461
Russell (ref_34) 2003; 72
Comeaux (ref_22) 2014; 46
Li (ref_36) 2014; 19
Kawale (ref_10) 2018; 46
Eldridge (ref_50) 1997; 11
Davies (ref_32) 2002; 324
ref_35
Pommier (ref_8) 2006; 6
Antony (ref_23) 2007; 35
Barthelmes (ref_17) 2004; 279
Jdey (ref_4) 2017; 23
Murai (ref_20) 2012; 287
Huang (ref_5) 2011; 21
Dexheimer (ref_24) 2009; 52
Lebedeva (ref_43) 2011; 585
Davis (ref_39) 2007; 12
Khomenko (ref_28) 2016; 24
Berman (ref_45) 2000; 28
Berman (ref_46) 2003; 10
ref_47
Lu (ref_1) 2017; 5
Nivens (ref_18) 2004; 53
Das (ref_14) 2009; 28
Dexheimer (ref_2) 2008; 8
Hirano (ref_16) 2007; 26
Allinger (ref_48) 1977; 99
Pommier (ref_9) 2010; 17
Interthal (ref_42) 2001; 98
Davies (ref_31) 2003; 10
Nguyen (ref_11) 2012; 55
Ponomarev (ref_30) 2018; 76
Laev (ref_3) 2016; 24
ref_7
Baxter (ref_51) 1998; 33
References_xml – volume: 46
  start-page: 494
  year: 2014
  ident: ref_22
  article-title: Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target
  publication-title: Drug Metab. Rev.
  doi: 10.3109/03602532.2014.971957
– volume: 76
  start-page: 392
  year: 2018
  ident: ref_30
  article-title: Aminoadamantanes Containing Monoterpene-derived Fragments as Potent Tyrosyl-DNA phosphodiesterase 1 Inhibitors
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2017.12.005
– volume: 18
  start-page: 4029
  year: 2011
  ident: ref_38
  article-title: Advances in bile acid medicinal chemistry
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986711796957266
– volume: 6
  start-page: 789
  year: 2006
  ident: ref_8
  article-title: Topoisomerase I inhibitors: Camptothecins and beyond
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1977
– volume: 26
  start-page: 4732
  year: 2007
  ident: ref_16
  article-title: Spinocerebellar ataxia with axonal neuropathy: Consequence of a Tdp1 recessive neomorphic mutation
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7601885
– volume: 98
  start-page: 12009
  year: 2001
  ident: ref_42
  article-title: The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.211429198
– volume: 781
  start-page: 37
  year: 2015
  ident: ref_12
  article-title: Tyrosyl-DNA-phosphodiesterase I (TDP1) participates in the removal and repair of stabilized-Top2α cleavage complexes in human cells
  publication-title: Mutat. Res.
  doi: 10.1016/j.mrfmmm.2015.09.003
– volume: 9
  start-page: 2044
  year: 2015
  ident: ref_25
  article-title: Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2015.03.020
– volume: 17
  start-page: 421
  year: 2010
  ident: ref_9
  article-title: DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
  publication-title: Chem. Biol.
  doi: 10.1016/j.chembiol.2010.04.012
– volume: 31
  start-page: 847
  year: 2012
  ident: ref_40
  article-title: Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study
  publication-title: Mol. Inf.
  doi: 10.1002/minf.201200103
– volume: 33
  start-page: 367
  year: 1998
  ident: ref_51
  article-title: Flexible Docking Using Tabu Search and an Empirical Estimate of Binding Affinity
  publication-title: Proteins Struct. Funct. Bioinform.
  doi: 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO;2-W
– volume: 42
  start-page: 3089
  year: 2014
  ident: ref_19
  article-title: TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkt1260
– volume: 17
  start-page: 1500
  year: 2010
  ident: ref_6
  article-title: Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986710790979971
– volume: 21
  start-page: 1285
  year: 2011
  ident: ref_5
  article-title: Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors
  publication-title: Expert Opin. Ther. Pat.
  doi: 10.1517/13543776.2011.604314
– volume: 55
  start-page: 4457
  year: 2012
  ident: ref_11
  article-title: Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors
  publication-title: J. Med. Chem.
  doi: 10.1021/jm300335n
– volume: 23
  start-page: 1001
  year: 2017
  ident: ref_4
  article-title: Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-1193
– volume: 287
  start-page: 12848
  year: 2012
  ident: ref_20
  article-title: Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.333963
– volume: 8
  start-page: 760
  year: 2009
  ident: ref_13
  article-title: Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin
  publication-title: DNA Repair
  doi: 10.1016/j.dnarep.2009.02.002
– volume: 86
  start-page: 388
  year: 2017
  ident: ref_37
  article-title: Modern approaches to modification of bile acids for the synthesis of compounds possessing valuable physicochemical and biological properties
  publication-title: Russ. Chem. Rev.
  doi: 10.1070/RCR4683
– volume: 10
  start-page: 980
  year: 2003
  ident: ref_46
  article-title: Announcing the worldwide Protein Data Bank
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsb1203-980
– volume: 58
  start-page: 3188
  year: 2015
  ident: ref_26
  article-title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b00136
– ident: ref_35
  doi: 10.3390/molecules22101710
– volume: 60
  start-page: 3275
  year: 2017
  ident: ref_27
  article-title: Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl-DNA phosphodiesterase 1 (Tdp1), and tyrosyl-DNA phosphodiesterase 2 (Tdp2)
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.6b01565
– volume: 24
  start-page: 5573
  year: 2016
  ident: ref_28
  article-title: New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2016.09.016
– volume: 324
  start-page: 917
  year: 2002
  ident: ref_32
  article-title: Insights into Substrate Binding and Catalytic Mechanism of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) from Vanadate and Tungstate-inhibited Structures
  publication-title: J. Mol. Biol.
  doi: 10.1016/S0022-2836(02)01154-3
– volume: 49
  start-page: 84
  year: 2009
  ident: ref_52
  article-title: Empirical scoring functions for advanced protein-ligand docking with PLANTS
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci800298z
– volume: 267
  start-page: 727
  year: 1997
  ident: ref_49
  article-title: Development and validation of a genetic algorithm for flexible docking
  publication-title: J. Mol. Biol.
  doi: 10.1006/jmbi.1996.0897
– volume: 72
  start-page: 137
  year: 2003
  ident: ref_34
  article-title: The enzymes, regulation, and genetics of bile acid synthesis
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.biochem.72.121801.161712
– ident: ref_47
– volume: 61
  start-page: 272
  year: 2005
  ident: ref_53
  article-title: General and targeted statistical potentials for protein-ligand interactions
  publication-title: Proteins Struct. Funct. Bioinform.
  doi: 10.1002/prot.20588
– volume: 11
  start-page: 425
  year: 1997
  ident: ref_50
  article-title: Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes
  publication-title: J. Comput.-Aided Mol. Des.
  doi: 10.1023/A:1007996124545
– volume: 65
  start-page: 55
  year: 1983
  ident: ref_44
  article-title: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
  publication-title: J. Immunol. Methods
  doi: 10.1016/0022-1759(83)90303-4
– volume: 585
  start-page: 683
  year: 2011
  ident: ref_43
  article-title: AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2011.01.032
– volume: 19
  start-page: 3761
  year: 2014
  ident: ref_36
  article-title: Synthesis and Biological Activity of Some Bile Acid-Based Camptothecin Analogues
  publication-title: Molecules
  doi: 10.3390/molecules19033761
– volume: 5
  start-page: e3933
  year: 2017
  ident: ref_1
  article-title: The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage
  publication-title: PeerJ
  doi: 10.7717/peerj.3933
– volume: 24
  start-page: 5017
  year: 2016
  ident: ref_3
  article-title: Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2016.09.045
– volume: 53
  start-page: 107
  year: 2004
  ident: ref_18
  article-title: Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase
  publication-title: Cancer Chemother. Pharmacol.
  doi: 10.1007/s00280-003-0717-6
– volume: 35
  start-page: 4474
  year: 2007
  ident: ref_23
  article-title: Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl–DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkm463
– volume: 28
  start-page: 3667
  year: 2009
  ident: ref_14
  article-title: Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK
  publication-title: EMBO J.
  doi: 10.1038/emboj.2009.302
– volume: 12
  start-page: 2106
  year: 2007
  ident: ref_39
  article-title: Bile Acid Scaffolds in Supramolecular Chemistry: The Interplay of Design and Synthesis
  publication-title: Molecules
  doi: 10.3390/12082106
– volume: 10
  start-page: 139
  year: 2003
  ident: ref_31
  article-title: Crystal Structure of a Transition State Mimic for Tdp1 Assembled from Vanadate, DNA, and a Topoisomerase I-Derived Peptide
  publication-title: Chem. Biol.
  doi: 10.1016/S1074-5521(03)00021-8
– volume: 55
  start-page: 1553
  year: 2014
  ident: ref_33
  article-title: Key discoveries in bile acid chemistry and biology and their clinical applications: History of the last eight decades
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R049437
– volume: 461
  start-page: 674
  year: 2009
  ident: ref_21
  article-title: A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage
  publication-title: Nature
  doi: 10.1038/nature08444
– volume: 279
  start-page: 55618
  year: 2004
  ident: ref_17
  article-title: TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M405042200
– ident: ref_54
– ident: ref_7
  doi: 10.1007/s40262-017-0587-4
– volume: 46
  start-page: 520
  year: 2018
  ident: ref_10
  article-title: Tyrosyl-DNA phosphodiesterases: Rescuing the genome from the risks of relaxation
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkx1219
– volume: 52
  start-page: 7122
  year: 2009
  ident: ref_24
  article-title: 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors
  publication-title: J. Med. Chem.
  doi: 10.1021/jm901061s
– volume: 8
  start-page: 381
  year: 2008
  ident: ref_2
  article-title: Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy
  publication-title: Anticancer Agents Med. Chem.
  doi: 10.2174/187152008784220357
– volume: 99
  start-page: 8127
  year: 1977
  ident: ref_48
  article-title: Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja00467a001
– volume: 26
  start-page: 4720
  year: 2007
  ident: ref_15
  article-title: TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7601869
– volume: 86
  start-page: 279
  year: 2014
  ident: ref_41
  article-title: Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2014.07.080
– volume: 79
  start-page: 2961
  year: 2016
  ident: ref_29
  article-title: Tyrosyl-DNA phosphodiesterase 1 inhibitors: Usnic acid enamines enhance the cytotoxic effect of camptothecin
  publication-title: J. Nat. Prod.
  doi: 10.1021/acs.jnatprod.6b00979
– volume: 28
  start-page: 235
  year: 2000
  ident: ref_45
  article-title: The Protein Data Bank
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/28.1.235
SSID ssj0021415
Score 2.3387861
Snippet An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 679
SubjectTerms amide
Bile
Bile Acids and Salts - chemical synthesis
Bile Acids and Salts - chemistry
Bile Acids and Salts - pharmacology
Binding Sites
cancer
chenodeoxycholic acid
deoxycholic acid
Deoxyribonucleic acid
DNA
DNA repair
Drug Evaluation, Preclinical
Enzymes
HCT116 Cells
Humans
MCF-7 Cells
Molecular Docking Simulation
molecular modelling
Niacinamide - analogs & derivatives
Niacinamide - chemical synthesis
Niacinamide - chemistry
Niacinamide - pharmacology
Phosphodiesterase Inhibitors - chemical synthesis
Phosphodiesterase Inhibitors - chemistry
Phosphodiesterase Inhibitors - pharmacology
Phosphoric Diester Hydrolases - metabolism
Tdp1 inhibitor
Tryptamines - chemical synthesis
Tryptamines - chemistry
Tryptamines - pharmacology
tumor
ursodeoxycholic acid
virtual screening
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF-kL_oifhutsoJPQugm-5Hk8dpaquAh2ELfwn7McgdnUsy1cP-9M5vc0VPRF193N2EyM5v5DbvzG8beixiFFtbmIRZNrqw2uUM_yoNqZK1q6jtKtcNf5ub8Un2-0ld3Wn3RnbCRHnhU3FFUGBOlK6WpS-Vd4TTYygbAf7uXUiX2Uox522RqSrUKjEvjGabEpP7o-9hqFgYE3ISRm70olMj6_4Qwf70oeSfynD1iDyfIyGejqI_ZPeiesPsn205tTxnM-1tY8W80sOkQ0eFCfoqudZtYvQfeR36Mu5_P_DIM3A585CzGOX6xQQE3q_x0PuNfF_1wvejpXiHVJQ_AC_6pWyzdklryPGOXZx8vTs7zqX1C7lHR69wL01SidqUACZURMjoVEK8hKmiMK3RU4CMCttJbpbXXJYQiiAakUSJiliGfs4Ou7-Al49YI8A5fQ6k0aNPUTgcVtKPKWsRkGRNbdbZ-4hanFherFnMMskD7mwUy9mH3yPVIrPG3xcdko91C4sROA-gp7eQp7b88JWOHWwu300Yd2pKqLzTCHJWxd7tpNBedm9gO-htckziHiM45Yy9Gh9hJUjYpg0QNVHuusifq_ky3XCQab0yFq0rqV__j216zByhlKpYsqkN2sP5xA28QLa3d27QxfgI2xhXQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
URI https://www.ncbi.nlm.nih.gov/pubmed/29562592
https://www.proquest.com/docview/2108551814
https://www.proquest.com/docview/2017056275
https://pubmed.ncbi.nlm.nih.gov/PMC6017735
https://doaj.org/article/f46633b236824cb1b5ea7adeeedc3345
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdge4AXxDcZozIST0jRnPgjyRNqt5WBRDXBJvUt8ldopZJ0Szep_z13TtpRQHvJg-0kJ9_Z_p19_h0hH1hVMcm0jl2VFLHQUsUG7Ch2ouC5yDHvKN4d_jZRZ5fi61RO-w23tg-r3MyJYaJ2jcU98qMUw-QlrEfi0_IqxqxReLrap9B4SPaRugxDurLpncOVwOrUnWRycO2PfnUJZ30LsBuRcrGzFgXK_v_hzL_DJf9Yf8ZPyZMeONJhp-ln5IGvn5NHx5t8bS-InzS3fkF_YMG6BlwHDekJGNht4PZuaVPREcwBdGjnrqW6pR1zMdTRizUIuF7EJ5MhPZ817XLWYHQh3k5uPU3ol3o2N3NMzPOSXI5PL47P4j6JQmyhu1exZarIWG5S5rnPFOOVEQ5QG2CDQplEVsLbCmBbarWQ0srUu8SxwnMlWAW-Bn9F9uqm9m8I1Yp5a-Az6FB7qYrcSCecNHi_FpBZRNimO0vbM4xjootFCZ4GaqD8RwMR-bh9ZdnRa9zXeIQ62jZEZuxQ0Fz_LPuBVlYCMBQ3KVd5KqxJjPQ6084DFrCcCxmRw42Gy364tuWdcUXk_bYa1IWnJ7r2zQ20CcxDSOockdedQWwlSYvgR0IPZDumsiPqbk09nwUyb3CIs4zLg_vFeksew__DZcgkOyR7q-sb_w7Q0MoMgsnDMx9_HpD90enk_Psg7Cz8BojsD_A
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-N8TBeEN9kDDASvCBFc2I7Hw8IdSulZVuFRCftLcSOQyuVpFu6of5T_I3c5aNQQHvba-w4J9_Z97vYdz-A1zzPueJp6ma5F7syVYGr0Y7cTMYikhHxjlLu8Mk4GJ7KT2fqbAt-drkwdK2y2xPrjTorDf0j3_fpmrxCfyTfL85dYo2i09WOQqMxiyO7-oEhW_Vu1Ef9vvH9wYfJ4dBtWQVcg99fuoYHccgj7XMrbBhwkWuZIYxBZxkH2lO5tCZHHOObVCpllG8zL-OxFYHkOYJvgePegttSiJhWVDT4uA7wPPSGzckpNvL97w3Bra0Q5hMyjzd8X00R8D9c-_f1zD_83eAe3G2BKus1lnUftmzxAHYOO364h2DH5ZWdsy_0YFUgjsSOrI8GfVXXEq9YmbMD3HNYz8yyiqUVayolYxubrFDA1dztj3vs87SsFtOSbjNSNnRlmcdGxXSmZ0QE9AhOb2R6H8N2URb2KbA04NZoHIYCeKuCONIqk5nSlM-LSNAB3k1nYtqK5kSsMU8wsiENJP9owIG361cWTTmP6zofkI7WHakSd_2gvPiWtAs7ySViNqF9EUS-NNrTyqZhmlnEHkYIqRzY6zSctNtDlfw2ZgderZtRXXRakxa2vMQ-daUjKiLtwJPGINaS-HEdt-IMhBumsiHqZksxm9bFwzEAD0Ohdq8X6yXsDCcnx8nxaHz0DO6gLHUiphfuwfby4tI-RyS21C9q82fw9abX2y-u0Eeb
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxLO4FFgkuCBZWXt3_TgglDZEDYWoEq2Um_G-SKRgp3ValL_Gr2PGj5QA6q1X79oa7czufOOdmY-QN8w5Jlme-8YFqS9yGfkK7Mg3IuWJSJB3FGuHv4yjw1PxaSInW-RXVwuDaZXdmVgf1KbU-I-8F2KavAR_JHquTYs4Hgw_LM58ZJDCm9aOTqMxkSO7-gnhW_V-NABdvw3D4ceTg0O_ZRjwNciy9DWL0pglKmSW2zhi3ClhANKA40wjFUgnrHaAaUKdCym1DK0JDEstjwRzAMQ5fPcWuR1zGeAeiydXwV4AnrG5ReU8Zb0fDdmtrQDyI0pPN_xgTRfwP4z7d6rmH75v-IDcb0Er7TdW9pBs2eIRuXvQccU9JnZcXto5_YoPVgVgSphIB2Dcl3Vf8YqWju7D-UP7emYqmle06ZoMY_RkBQKu5v5g3KfH07JaTEvMbMTK6MrSgI6K6UzNkBToCTm9keV9SraLsrDPCM0jZrWCz2Awb2WUJkoaYaTC2l5AhR5h3XJmuu1ujiQb8wyiHNRA9o8GPPJu_cqiae1x3eR91NF6Inblrh-U59-zdpNnTgB-4yrkURIKrQIlbR7nxgIO0ZwL6ZG9TsNZe1RU2ZVhe-T1ehjUhTc3eWHLC5hTdz3ChtIe2WkMYi1JmNYxLKxAvGEqG6JujhSzad1IHILxGGx393qxXpE7sNOyz6Px0XNyD0SpazKDeI9sL88v7AsAZUv1srZ-Sr7d9Hb7DaT1S8g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+Semisynthetic+Derivatives+of+Bile+Acids+as+Effective+Tyrosyl-DNA+Phosphodiesterase+1+Inhibitors&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Salomatina%2C+Oksana&rft.au=Popadyuk%2C+Irina&rft.au=Zakharenko%2C+Alexandra&rft.au=Zakharova%2C+Olga&rft.date=2018-03-17&rft.issn=1420-3049&rft.eissn=1420-3049&rft.volume=23&rft.issue=3&rft.spage=679&rft_id=info:doi/10.3390%2Fmolecules23030679&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_molecules23030679
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon